Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06689865 · ClinicalTrials.gov registry record · NA
Innovations in Hearing Accessibility and Technology (IHAT) Study
A NA study of Hearing Loss and Hearing Aids, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 280
- Enrollment target
- 2
- Study locations
NCT06689865: Recruiting NA study of Hearing Loss and Hearing Aids, sponsored by University of Colorado, Denver.
NCT06689865 is a NA study of Hearing Loss and Hearing Aids that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 280 participants, below the 6,116-participant average among 58 other Hearing Loss trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06689865, a NA study of Hearing Loss and Hearing Aids, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
- 2
- Study locations
Study Summary
The research will explore outcomes of different service delivery models of over-the-counter (OTC) hearing aids by comparing them to prescription hearing aids fitted by specialists in individuals with mild to moderate hearing loss. The investigators will examine how each type affects users' experiences, behavior, thinking skills, and brain activity related to hearing. Additionally, the study will focus on what types of people prefer each hearing aid option, what helps or hinders these choices, and compare the costs of four different service options. This approach will help transition from research findings into real-world practice, providing useful information for healthcare providers and policymakers about OTC hearing aid options.
Primary Outcome
It is a 24-item self-reported measure of hearing disability and hearing aid benefit. It includes four subscales that address different listening challenges: ease of communication, reverberation, background noise, and aversiveness of sounds, with each subscales comprising six items. The ease of communication, reverberation, and background noise primarily measure challenges related to speech communication. The global score on the APHAB is the average of these three subscale scores. The hearing aid
Conditions Studied
Interventions
- DEVICE HA-HCP
- DEVICE OTC-HCP
- DEVICE OTC-R
- DEVICE OTC-SF
Study Locations (2)
Colorado
- University of Colorado School of Medicine - Aurora
- University of Colorado Boulder - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2024-11-13 |
| Est. Completion | 2029-03-31 |
| Phase | NA |
What NCT06689865 shows while recruiting
NCT06689865 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 6,116-participant average among 58 other Hearing Loss trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Hearing Loss appearing as the primary indexed condition, and to 4 interventions - of which HA-HCP is the first listed.
NCT06689865 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06689865 about?
NCT06689865 is a clinical study titled "Innovations in Hearing Accessibility and Technology (IHAT) Study". The research will explore outcomes of different service delivery models of over-the-counter (OTC) hearing aids by comparing them to prescription hearing aids fitted by specialists in individuals with mild to moderate hearing loss. The investigators will examine how each type affects users' experienc...
What is the current status of trial NCT06689865?
This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2024-11-13. Estimated completion is 2029-03-31.
What conditions does trial NCT06689865 study?
This clinical trial studies the following conditions: Hearing Loss, Hearing Aids, OTC Hearing Aids.
What interventions are being tested in trial NCT06689865?
The interventions under investigation include: HA-HCP (DEVICE), OTC-HCP (DEVICE), OTC-R (DEVICE), OTC-SF (DEVICE).
Who is sponsoring clinical trial NCT06689865?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06689865 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06689865's enrollment target sits among peer trials
280 21st of 58 higher than 38 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI